AstraZeneca Faces Another Setback as Galida Filing Delayed AstraZeneca Plc, the UK #39;s second-biggest drugmaker, delayed the regulatory filing of its diabetes medicine Galida by a year to 2007, a setback that comes a month after US scientists questioned 